EU Biosimilar Action: New Competitors For Remicade/Herceptin, Four More Products Await CHMP OK

 
• By Ian Schofield
  
Approved
The EU has approved more biosimilar versions of Remicade and Herceptin
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews